Table 1 Demographics table: Baseline data of the study population (n = 30).
Age (years) (mean ± SD) | 54.4 ± 11.3 |
|---|---|
Gender (male) (%) | 57 (n = 17) |
Positive genetic study (%) | 37 |
History of syncope (%) | 13 |
Non-sustained VT on Holter (%) | 43 |
Familiar history of SCD (%) | 33 |
Previous ICD implantation (%) | 47 |
LA diameter (mm, mean ± SD) | 42.5 ± 7.73 |
LA volume (ml/m2) (mean ± SD) | 45.5 ± 16.8 |
Maximum wall thickness (mm ± SD, IQR) | 20.3 ± 4.39; 17–23 |
Medications | |
Beta-blockers | 93.3% |
Calcium channel blockers | 6.7% |
ACE inhibitors/ ARBs | 30% |
Diuretics | 10% |
Oral anticoagulants | 23.3% |
Oral anti-diabetic drugs | 10% |
Group III anti-arrhythmic drugs | 13.3% |
SCD score (%) (mean ± SD) | 3.7 ± 2.5 |
SCD score ≥ 4% (%) | 30 |
